Tim Smith

Research finds potential benefits to using apremilast for plaque psoriasis patients.

A study from the Netherlands suggests steps to address patients’ sleep health.

A study in China found that Parkinson’s patients treated with acupuncture saw reduced anxiety levels.

A discussion on research into allergic contact dermatitis and its connection to allergens in skincare products.

Officials with the US Preventive Services Task Force have new recommendations for adult mental health screens.

A recent study in China aligns with findings regarding lower life quality rankings for older adults.

The results of two phase 3 clinical trials suggest a topical psoriasis treatment option.

Research upholds prior recommendations for treating younger patients hospitalized with influenza.

New findings illuminate the need for clinicians to address sleep issues for patients with autism.

A discussion on the recent success of phase 3 trials regarding chronic sinusitis and nasal polyp treatment.

French researchers find that targeted allergy assessments may be needed in children with peanut allergies.

There is a high risk for contact dermatitis in retail products for skincare, due to the prevalence of allergens.

Due to the lack of a standard set of ‘good sleep’ criteria, a questionnaire was developed to help gauge criteria for sleep health.

Research shown at EADV 2022 demonstrated the efficacy of an antibody designed to protect against inflammatory skin disorders.

Research from a double-blind trial suggests a lack of need for clinicians to implement glutamine therapy for burn victims.

New research presented at EADV 2022 suggests positive results for a new JAK1-selective inhibitor for hidradenitis suppurativa.

Dr. Reid Robison, MD, MBA, described his research on clinical depression and the recent acceptance of psychedelic medicine.

A pair of phase 3 clinical trials presented at EADV 2022 indicate dupilumab significantly improves PN symptoms over 24 weeks.

Large numbers of vitiligo patients around the world have reported differing outcomes, with darker skin types expressing the more significant severity, according to new findings.

Research presented at EADV 2022 sees positive outcomes with the targeted therapy for patients of varied backgrounds with vitiligo.

The pandemic may have both widened the vaccination coverage gap between rural and urban adolescents and affected vaccination coverage in general.

A research letter by Emory University investigators found racial disparities in temperature measurements for Black and White hospital patients.

Rebecca T. Brown, MD, MPH, describes contributing factors to older homeless adult mortality and future topics of interest in this field.

The latest indications for the novel selective antibody will make it available as a treatment for pustular psoriasis.

A study from Germany elucidated new information on the rare uncombable hair syndrome, changing the ways in which the syndrome may be analyzed.

Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.

Recent research from George Washington University analyzed the effects of COVID-19 on recruitment and funding for medical school pathway programs.

An Oakland-based analysis of mortality among homeless adults aged ≥50 years old illuminates the need for more proactive homeless care policies.

A recent study developed framework to improve fall prevention methodology across the country’s primary health care system.

A recent study in Finland finds 2 major contributing factors to allergic disease in infants with familial risk.